If approved, rezafungin will be the first new drug for the treatment of candidemia and invasive candidiasis in over a decade SAN DIEGO and PARSIPPANY, N.J., Jan. 25, 2023 (GLOBE NEWSWIRE) -- Cidara ...
Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. A Food and Drug Administration expert panel of advisors voted 11-0 ...
The completion of the Human Genome Project in 2003 marked a turning point in medicine, sparking widespread optimism about a future where diseases could be predicted, prevented, and treated with ...
Approval given after Safety Review Committee (SRC) review of safety data from the three patients comprising Cohort 2 No significant safety or dose limiting toxicities reported in Cohort 2 New patients ...
A key FDA advisory committee rejected the use of a psychedelic drug to help patients struggling with PTSD, questioning its safety and effectiveness. The FDA must now decide whether it will follow suit ...
Lykos Therapeutics’ attempt to get the first ever MDMA treatment approved in post-traumatic stress disorder suffered a crushing blow yesterday when an FDA advisory committee voted against recommending ...
A clinical expert explained that rheumatoid arthritis has a devastating effect on a person's quality of life and almost 1 in 3 people stop work within 2 years of diagnosis. The patient experts ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback